Brief: Ocean Biomedical, Inc. (Nasdaq OCEA) Announces Patent Award For Novel Cancer Immunotherapy Treatment
23/05/2023 13:23
May 23 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL, INC. (NASDAQ: OCEA) ANNOUNCES PATENT
AWARD FOR
NOVEL CANCER IMMUNOTHERAPY TREATMENT, GRANTED FOR PROSTATE
CANCER, COLON CANCER, OVARIAN CANCER, KIDNEY CANCER, BREAST
CANCER, GLIOBLASTOMA, MELANOMA, AND LUNG CANCER.
Source text for Eikon: ID:nGNX1ly4JF
Further company coverage: OCEA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26